{
  "meta": {
    "data_length": 1,
    "message": "Proposition id 534 retrieved successfully",
    "request_url": "http://api.moalmanac.org/propositions?proposition_id=534",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.025175,
    "timestamp_received": "2026-06-08T19:59:20.968141+00:00Z",
    "timestamp_returned": "2026-06-08T19:59:20.993316+00:00Z",
    "trace_id": "573ebdc7-8dfd-4e38-9cd8-4e36547d8eff"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://dev.moalmanac.org",
    "last_updated": "2026-05-07"
  },
  "data": [
    {
      "id": 534,
      "type": "VariantTherapeuticResponseProposition",
      "predicate": "predictSensitivityTo",
      "biomarkers": [
        {
          "id": 0,
          "name": "CD30 +",
          "genes": [],
          "type": "CategoricalVariant",
          "extensions": [
            {
              "name": "biomarker_type",
              "value": "Protein expression"
            },
            {
              "name": "present",
              "value": true
            },
            {
              "name": "marker",
              "value": "CD30"
            },
            {
              "name": "unit",
              "value": "status"
            },
            {
              "name": "equality",
              "value": "="
            },
            {
              "name": "value",
              "value": "Positive"
            }
          ]
        }
      ],
      "subjectVariant": {},
      "conditionQualifier": {
        "id": 30,
        "conceptType": "Disease",
        "name": "Cutaneous T-cell Lymphoma",
        "primaryCoding": {
          "id": "ncit:C3467",
          "code": "C3467",
          "name": "Primary Cutaneous T-Cell Non-Hodgkin Lymphoma",
          "system": "https://evsexplore.semantics.cancer.gov",
          "systemVersion": "25.01d",
          "iris": [
            "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C3467"
          ]
        },
        "mappings": []
      },
      "objectTherapeutic": {
        "id": 0,
        "conceptType": "Drug",
        "name": "Brentuximab vedotin",
        "primaryCoding": {
          "id": "ncit:C66944",
          "code": "C66944",
          "name": "Brentuximab Vedotin",
          "system": "https://evsexplore.semantics.cancer.gov",
          "systemVersion": "25.01d",
          "iris": [
            "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C66944"
          ]
        },
        "mappings": [
          {
            "relation": "relatedMatch",
            "coding": {
              "id": "rxcui:1147320",
              "code": "1147320",
              "name": "brentuximab vedotin",
              "system": "RxNorm",
              "systemVersion": "20250602",
              "iris": [
                "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1147320"
              ]
            }
          },
          {
            "relation": "relatedMatch",
            "coding": {
              "id": "omop:37017170",
              "code": "37017170",
              "name": "Brentuximab vedotin",
              "system": "OMOP",
              "systemVersion": "v20250827",
              "iris": [
                "https://athena.ohdsi.org/search-terms/terms/37017170"
              ]
            }
          },
          {
            "relation": "relatedMatch",
            "coding": {
              "id": "sctid:713395006",
              "code": "713395006",
              "name": "Brentuximab vedotin",
              "system": "SNOMED",
              "systemVersion": "2025-03-01",
              "iris": [
                "https://browser.ihtsdotools.org/?perspective=full&conceptId1=713395006&edition=MAIN/2025-03-01&release=&languages=en"
              ]
            }
          },
          {
            "relation": "relatedMatch",
            "coding": {
              "id": "omop:40241969",
              "code": "40241969",
              "name": "brentuximab vedotin",
              "system": "OMOP",
              "systemVersion": "v20250827",
              "iris": [
                "https://athena.ohdsi.org/search-terms/terms/40241969"
              ]
            }
          }
        ],
        "extensions": [
          {
            "name": "therapy_strategy",
            "value": [
              "target CD30 antigens"
            ],
            "description": "Associated therapeutic strategy or mechanism of action of the therapy."
          },
          {
            "name": "therapy_type",
            "value": "Targeted therapy",
            "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
          }
        ]
      }
    }
  ]
}